Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2004
12/08/2004EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004EP1341754B1 Substituted anthranilic acids
12/08/2004EP1216227B1 Preparation of sulfonyl imine compounds
12/08/2004EP0915868B1 Carbanilides used as pesticides
12/08/2004CN1553895A Taxol enhancer compounds
12/08/2004CN1553894A Taxol enhancer compounds
12/08/2004CN1553893A Synthesis of taxol enhancers
12/08/2004CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004CN1552706A Chemical synthesis method for acyl thiophene
12/08/2004CN1552705A Alkylation of thiophene compounds and their use in desulfuration of fractional oil
12/08/2004CN1552682A Method for preparing purified petroleum benzine and concentrating thiofuran by cruden benzol
12/08/2004CN1178913C Aromatic heterocycle compounds having HIV integrase inhibiting activities
12/07/2004US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/02/2004WO2004103990A1 Process for producing optically active n-monoalkyl-3­hydroxy-3-arylpropylamine compound and intermediate
12/02/2004WO2004103951A1 Method for producing an optically active nitro compound
12/02/2004WO2004103941A2 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
12/02/2004WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004US20040242901 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems
12/02/2004US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004US20040242685 Administering -4-benzyloxy-3,5-dimethoxy-N-[(1-dimethylaminocyclopentyl)methyl]benzamide or derivatives for treating disorders responsive to inhibition of the GlyT-2 transporter, such as muscle spasticity, epilepsy and acute, chronic and neuropathic pain
12/02/2004US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004US20040242584 Muscarinic agonists
12/02/2004US20040242573 Novel compounds
12/02/2004US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/02/2004US20040237214 Aniline, thiophene, furan, thiazole, triazole or pyrazole dye couplers; hair dyes with improved colorfastness, washfastness and photostability
12/02/2004CA2525310A1 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
12/01/2004EP1482575A2 Stable solutions of organic semiconductor materials
12/01/2004EP1481970A1 Novel herbicides
12/01/2004EP1481967A1 Process for the preparation of biaryl compounds
12/01/2004EP1481012A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
12/01/2004EP1480967A1 Novel fused ring compounds, and their use as cationic photoinitiators
12/01/2004EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004EP1480944A2 Substituted aryl ketones
12/01/2004EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004CN1551875A M-aminophenol derivatives and coloring agents containing them
12/01/2004CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
12/01/2004CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004US6825360 Bicyclic aromatic compounds
11/30/2004US6825359 Quinomethane compounds
11/30/2004US6825358 Synthesis of soluble derivatives of sexithiophene and their use as the semiconducting channels in thin-film field-effect transistors
11/30/2004US6825354 Osteoporosis; rheumatic diseases
11/30/2004US6825352 Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors
11/30/2004US6825235 Synthesis of taxol enhancers
11/30/2004US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004US6824706 Oxidative stability; processibility; easy to synthesize; high charge mobility
11/30/2004CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/25/2004WO2004101545A1 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
11/25/2004WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004WO2004101491A1 Arylamine compound and organic electroluminescence device containing the same
11/25/2004WO2004085385A3 Cannabinoid receptor ligands
11/25/2004WO2004084842A3 Inhibitors of cathepsin s
11/25/2004WO2004069133A3 N-monoacylated o-phenylenediamines as anti -cancer agents
11/25/2004US20040236115 Synthesis of cyclopentadiene derivatives
11/25/2004US20040236104 Substituted 4-aminocyclohexanols
11/25/2004US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004US20040235958 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
11/25/2004US20040235927 Synthesis and antimicrobial activity of novel dicationic "reversed amidines"
11/25/2004US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004US20040235885 Novel composition and method for stabilizing the same
11/25/2004US20040235859 Novel piperazine derivatives
11/25/2004US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004US20040234958 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
11/25/2004US20040232384 Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same
11/25/2004US20040231064 3-Aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
11/25/2004CA2526086A1 Heterocyclic compounds
11/25/2004CA2525684A1 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
11/25/2004CA2525438A1 Glyoxalase inhibitors
11/24/2004EP1479666A1 Ester compound and medicinal use thereof
11/24/2004EP1478641A1 Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine
11/24/2004EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004EP1478364A2 Selective antibacterial agents
11/24/2004EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004CN1548434A Benzothiophene compounds and their prepn and medicine use
11/24/2004CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004CN1176900C Process for hydrogenation of imines
11/24/2004CN1176646C Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
11/23/2004US6822384 Design and synthesis of advanced NLO materials for electro-optic applicators
11/23/2004US6822118 Catalytic reaction using iridium compound under high pressure in presence of metal- or ammonium- chloride, bromide, or iodide and acid
11/23/2004US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders